← Open Payments lookup

ROBERT RIFKIN: Open Payments

NPI 1639289051 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,234 in 64 payments from 15 companies in 2025. Trend: 2023 $3,227 · 2024 $1,677 · 2025 $1,234

Food & beverage: $1,234
CompanyPaymentsAmount
ABBVIE INC.15$253
Otsuka America Pharmaceutical, Inc.7$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$151
TMS NeuroHealth Centers Inc.1$98
Corium, LLC4$93
Alkermes, Inc.4$83
Takeda Pharmaceuticals U.S.A., Inc.4$72
Neurocrine BioSciences, Inc.4$69
Axsome Therapeutics, Inc.3$48
Noven Therapeutics, LLC3$47

Products named: VRAYLAR, CAPLYTA, REXULTI, TMS NeuroHealth Centers Inc., Azstarys, TRINTELLIX, INGREZZA, ABILIFY MAINTENA.

Industry payments across MO — which companies pay providers there.